Leadership changes
Executive appointments and departures from SEC 8-K filings, updated within hours of each filing.
Updated Nov 6, 2026
Changes, November 2026
292
Appointments
143
Departures
34
Browse by role
Get new CFO appointments the day the filing lands.
Browse by month
Filters
3,420 changes
| Filing date | Company | Person | Role | Change | Effective date | Source |
|---|---|---|---|---|---|---|
| Oct 19, 2026 | STANDEX INTERNATIONAL CORP/DE/ | Samantha L. Stoddard | Vice President, Chief Financial Officer and TreasurerCFO | Appointed | Dec 1, 2026 | SEC 8-K |
| Oct 19, 2026 | STANDEX INTERNATIONAL CORP/DE/ | Ademir Sarcevic | Chief Financial Officer, Treasurer and principal financial officerCFO | Departed | Dec 1, 2026 | SEC 8-K |
| Oct 19, 2026 | Stardust Power Inc. | Udaychandra Devasper | Chief Financial OfficerCFO | Departed | Oct 23, 2026 | SEC 8-K |
| Oct 19, 2026 | Tamboran Resources Corp | Todd Abbott | Managing DirectorManaging Director | Appointed | Oct 19, 2026 | SEC 8-K |
| Oct 19, 2026 | Tamboran Resources Corp | Todd Abbott | Class II directorClass II director | Appointed | n/a | SEC 8-K |
| Oct 19, 2026 | TCGX Acquisition Corp. II | Joshua Cohen | DirectorDirector | Appointed | Oct 15, 2026 | SEC 8-K |
| Oct 19, 2026 | TCGX Acquisition Corp. II | Mark McKenna | DirectorDirector | Appointed | Oct 15, 2026 | SEC 8-K |
| Oct 19, 2026 | TCGX Acquisition Corp. II | Michael Henderson, M.D. | DirectorDirector | Appointed | Oct 15, 2026 | SEC 8-K |
| Oct 19, 2026 | Tempest Therapeutics, Inc. | John Frederick | Class III directorClass III director | Appointed | Oct 13, 2026 | SEC 8-K |
| Oct 19, 2026 | Torrid Holdings Inc. | Paula Dempsey | Chief Financial OfficerCFO | Departed | Nov 12, 2026 | SEC 8-K |
| Oct 19, 2026 | Torrid Holdings Inc. | Will Langley | Interim Chief Financial OfficerCFO | Appointed | Oct 28, 2026 | SEC 8-K |
| Oct 19, 2026 | Vaxart, Inc. | Raquel C. Bono, M.D., M.B.A., FACS | DirectorDirector | Appointed | Oct 16, 2026 | SEC 8-K |
| Oct 19, 2026 | Venu Holding Corp | William Hodgson | PresidentPresident | Departed | Oct 13, 2026 | SEC 8-K |
| Oct 19, 2026 | WILLIAMS SONOMA INC | Lynn Martin | director of the Companydirector of the Company | Appointed | Oct 19, 2026 | SEC 8-K |
| Oct 20, 2026 | Apollo Global Management, Inc. | Meyer “Micky” Malka | directordirector | Appointed | Jan 1, 2027 | SEC 8-K |
| Oct 20, 2026 | Clearfield, Inc. | Cheryl Beranek | President and Chief Executive OfficerCEO | Departed | Mar 31, 2027 | SEC 8-K |
| Oct 20, 2026 | Fox Corp | Adam Ciongoli | Chief Legal and Policy OfficerCLO | Departed | Dec 1, 2026 | SEC 8-K |
| Oct 20, 2026 | Fox Corp | Nicholas Trutanich | General CounselCLO | Appointed | Dec 1, 2026 | SEC 8-K |
| Oct 20, 2026 | HUNTINGTON INGALLS INDUSTRIES, INC. | C. Michael Petters | DirectorDirector | Appointed | Oct 19, 2026 | SEC 8-K |
| Oct 20, 2026 | Inhibikase Therapeutics, Inc. | Dennis Berman | directordirector | Departed | Oct 19, 2026 | SEC 8-K |
- STANDEX INTERNATIONAL CORP/DE/Appointed
Samantha L. Stoddard CFO
Filed Oct 19, 2026Effective Dec 1, 2026SEC 8-K
- STANDEX INTERNATIONAL CORP/DE/Departed
Ademir Sarcevic CFO
Filed Oct 19, 2026Effective Dec 1, 2026SEC 8-K
- Stardust Power Inc.Departed
Udaychandra Devasper CFO
Filed Oct 19, 2026Effective Oct 23, 2026SEC 8-K
- Tamboran Resources CorpAppointed
Todd Abbott Managing Director
Filed Oct 19, 2026Effective Oct 19, 2026SEC 8-K
- Tamboran Resources CorpAppointed
Todd Abbott Class II director
Filed Oct 19, 2026SEC 8-K
- TCGX Acquisition Corp. IIAppointed
Joshua Cohen Director
Filed Oct 19, 2026Effective Oct 15, 2026SEC 8-K
- TCGX Acquisition Corp. IIAppointed
Mark McKenna Director
Filed Oct 19, 2026Effective Oct 15, 2026SEC 8-K
- TCGX Acquisition Corp. IIAppointed
Michael Henderson, M.D. Director
Filed Oct 19, 2026Effective Oct 15, 2026SEC 8-K
- Tempest Therapeutics, Inc.Appointed
John Frederick Class III director
Filed Oct 19, 2026Effective Oct 13, 2026SEC 8-K
- Torrid Holdings Inc.Departed
Paula Dempsey CFO
Filed Oct 19, 2026Effective Nov 12, 2026SEC 8-K
- Torrid Holdings Inc.Appointed
Will Langley CFO
Filed Oct 19, 2026Effective Oct 28, 2026SEC 8-K
- Vaxart, Inc.Appointed
Raquel C. Bono, M.D., M.B.A., FACS Director
Filed Oct 19, 2026Effective Oct 16, 2026SEC 8-K
- Venu Holding CorpDeparted
William Hodgson President
Filed Oct 19, 2026Effective Oct 13, 2026SEC 8-K
- WILLIAMS SONOMA INCAppointed
Lynn Martin director of the Company
Filed Oct 19, 2026Effective Oct 19, 2026SEC 8-K
- Apollo Global Management, Inc.Appointed
Meyer “Micky” Malka director
Filed Oct 20, 2026Effective Jan 1, 2027SEC 8-K
- Clearfield, Inc.Departed
Cheryl Beranek CEO
Filed Oct 20, 2026Effective Mar 31, 2027SEC 8-K
- Fox CorpDeparted
Adam Ciongoli CLO
Filed Oct 20, 2026Effective Dec 1, 2026SEC 8-K
- Fox CorpAppointed
Nicholas Trutanich CLO
Filed Oct 20, 2026Effective Dec 1, 2026SEC 8-K
- HUNTINGTON INGALLS INDUSTRIES, INC.Appointed
C. Michael Petters Director
Filed Oct 20, 2026Effective Oct 19, 2026SEC 8-K
- Inhibikase Therapeutics, Inc.Departed
Dennis Berman director
Filed Oct 20, 2026Effective Oct 19, 2026SEC 8-K